Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

BACKGROUND: Following the release of the 2002 report of the Women’s Health Initiative (WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dropped, suggesting a cause-and-effect r...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chlebowski, Rowan T., Kuller, Lewis H., Prentice, Ross L., Stefanick, Marcia L., Manson, JoAnn E., Gass, Margery, Aragaki, Aaron K., Ockene, Judith K., Lane, Dorothy S., Sarto, Gloria E., Rajkovic, Aleksandar, Schenken, Robert, Hendrix, Susan L., Ravdin, Peter M., Rohan, Thomas E., Yasmeen, Shagufta, Anderson, Garnet
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963492/
https://ncbi.nlm.nih.gov/pubmed/19196674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0807684
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires